CGTX•benzinga•
Cognition Therapeutics Says Masked Analysis Showed Participants Receiving Oral Zervimesine For At Least Least 6 Months Experienced Slower Lesion Growth Than Participants Receiving Placebo
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 26, 2025 by benzinga